UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis

Respiratory research, 2022-06, Vol.23 (1), p.1-169, Article 169

2022

Volltextzugriff (PDF)

Humoral Immune Status in Relation to Outcomes in Patients with Idiopathic Pulmonary Fibrosis

Lung, 2021-12, Vol.199 (6), p.667-676

2021

Volltextzugriff (PDF)

The detrimental effect of quantity of smoking on survival in progressive fibrosing ILD

Respiratory medicine, 2022-04, Vol.194, p.106760-106760, Article 106760

2022

Volltextzugriff (PDF)

Bronchoalveolar lavage characteristics correlate with HLA tag SNPs in patients with Löfgren’s syndrome and other sarcoidosis

Clinical and experimental immunology, 2019-05, Vol.196 (2), p.249-258

2019

Volltextzugriff (PDF)

Systemic cytokine response in patients with community-acquired pneumonia

The European respiratory journal, 2011-06, Vol.37 (6), p.1431-1438

2011

Volltextzugriff (PDF)

Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis

Clinical and experimental immunology, 2015-08, Vol.181 (2), p.357-361

2015

Volltextzugriff (PDF)

Genetic variability in the IL1RN gene and the balance between interleukin (IL)‐1 receptor agonist and IL‐1β in idiopathic pulmonary fibrosis

Clinical and experimental immunology, 2011-12, Vol.166 (3), p.346-351

2011

Volltextzugriff (PDF)

Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis

Clinical and experimental immunology, 2016-08, Vol.185 (2), p.263-270

2016

Volltextzugriff (PDF)

Change in Serum Biomarker CA 15-3 as an Early Predictor of Response to Treatment and Survival in Hypersensitivity Pneumonitis

Lung, 2020-04, Vol.198 (2), p.385-393

2020

Volltextzugriff (PDF)

Lung Transplantation Has a Strong Impact on the Distribution and Phenotype of Monocyte Subsets

Transplantation proceedings, 2020-04, Vol.52 (3), p.958-966

2020

Volltextzugriff (PDF)

MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases

Clinical and experimental immunology, 2010-08, Vol.161 (2), p.342-347

2010

Volltextzugriff (PDF)

Toll-like receptor (TLR)-9 genetics and function in sarcoidosis

Clinical and experimental immunology, 2010-10, Vol.162 (1), p.68-74

2010

Volltextzugriff (PDF)

Linkage between Toll‐like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis

Clinical and experimental immunology, 2007-09, Vol.149 (3), p.453-462

2007

Volltextzugriff (PDF)

Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Löfgren’s syndrome

Cytokine (Philadelphia, Pa.), 2014-10, Vol.69 (2), p.272-276

2014

Volltextzugriff (PDF)

Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis

Sarcoidosis, vasculitis, and diffuse lung diseases, 2009-07, Vol.26 (2), p.155-161

2009

Volltextzugriff (PDF)

Variation in IL7R predisposes to sarcoid inflammation

Genes and immunity, 2009-10, Vol.10 (7), p.647-653

2009

Volltextzugriff (PDF)

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines

British Journal of Cancer, 1999-06, Vol.80 (7), p.981-990

1999

Volltextzugriff (PDF)

Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis

The European respiratory journal, 2014-02, Vol.43 (2), p.602-609

2014

Volltextzugriff (PDF)

YKL-40 and matrix metalloproteinases as potential biomarkers of inflammation and fibrosis in the development of bronchiolitis obliterans syndrome

Sarcoidosis, vasculitis, and diffuse lung diseases, 2013-03, Vol.30 (1), p.28-35

2013

Volltextzugriff (PDF)

Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis

Expert review of respiratory medicine, 2020-07, Vol.14 (7), p.749-756

2020

Volltextzugriff (PDF)

Toll‐like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients

Clinical and experimental immunology, 2006-08, Vol.145 (2), p.215-218

2006

Volltextzugriff (PDF)

Effect of variation in ITGAE on risk of sarcoidosis, CD103 expression, and chest radiography

Clinical immunology (Orlando, Fla.), 2009-10, Vol.133 (1), p.117-125

2009

Volltextzugriff (PDF)

Predicting prognosis in idiopathic pulmonary fibrosis

Sarcoidosis, vasculitis, and diffuse lung diseases, 2010-07, Vol.27 (2), p.85-95

2010

Volltextzugriff (PDF)

Evaluation of automated airway morphological quantification for assessing fibrosing lung disease

Computer methods in biomechanics and biomedical engineering., 2024-12, Vol.12 (1)

2024

Volltextzugriff (PDF)

Gemcitabine–cisplatin: A schedule finding study

Annals of oncology, 1999-12, Vol.10 (12), p.1503-1510

1999

Volltextzugriff (PDF)

1 – 25 von 312

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(276)
Mit Volltextzugriff
(279)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis

Humoral Immune Status in Relation to Outcomes in Patients with Idiopathic Pulmonary Fibrosis

The detrimental effect of quantity of smoking on survival in progressive fibrosing ILD

Bronchoalveolar lavage characteristics correlate with HLA tag SNPs in patients with Löfgren’s syndrome and other sarcoidosis

Systemic cytokine response in patients with community-acquired pneumonia

Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis

Genetic variability in the IL1RN gene and the balance between interleukin (IL)‐1 receptor agonist and IL‐1β in idiopathic pulmonary fibrosis

Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis

Change in Serum Biomarker CA 15-3 as an Early Predictor of Response to Treatment and Survival in Hypersensitivity Pneumonitis

Lung Transplantation Has a Strong Impact on the Distribution and Phenotype of Monocyte Subsets

MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases

Toll-like receptor (TLR)-9 genetics and function in sarcoidosis

Linkage between Toll‐like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis

Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Löfgren’s syndrome

Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis

Variation in IL7R predisposes to sarcoid inflammation

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines

Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis

YKL-40 and matrix metalloproteinases as potential biomarkers of inflammation and fibrosis in the development of bronchiolitis obliterans syndrome

Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis

Toll‐like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients

Effect of variation in ITGAE on risk of sarcoidosis, CD103 expression, and chest radiography

Predicting prognosis in idiopathic pulmonary fibrosis

Evaluation of automated airway morphological quantification for assessing fibrosing lung disease

Gemcitabine–cisplatin: A schedule finding study

Suchergebnisse filtern